表紙
市場調查報告書

NGS為基礎的RNA定序的全球市場:SBS,SMRT,奈米孔洞 - 至2024年的預測

NGS-Based RNA-Sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 509324
出版日期 內容資訊 英文 157 Pages
訂單完成後即時交付
價格
NGS為基礎的RNA定序的全球市場:SBS,SMRT,奈米孔洞 - 至2024年的預測 NGS-Based RNA-Sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region - Global Forecast to 2024
出版日期: 2019年09月27日內容資訊: 英文 157 Pages
簡介

全球NGS為基礎的RNA定序的市場規模預測將從2019年17億美元,成長到2024年的42億美元,並以20.0%的年複合成長率 (CAGR) 成長。市場成長的主要原因,是RNA定序的政府輔助金的增額,及研究開發 (R&D) 活動的活躍化,精密醫療的急速成長等。各用途中表現分析佔最大的佔有率,以及各地區中亞太地區今後預計將急速成長。

本報告提供全球NGS (次世代定序) 為基礎的RNA-Seq (RNA序列) 市場相關分析,市場基本結構和最新形勢,主要市場促進、阻礙因素,市場趨勢預測 (過去2年、今後6年份),各產品/服務、各技術、各用途、各地區的詳細趨勢,市場競爭的狀態,主要企業簡介等調查。

第1章 簡介

第2章 分析方法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
      • 對傳統手法的RNA定序的優點
      • RNA定序津貼的增加
      • RNA定序相關的研究活動的增加
      • 精密醫療的急速成長
    • 阻礙因素
      • 在研究領域的RNA定序的利用增加
      • 體檢檢驗的RNA定序的標準化的問題
    • 市場機會
      • 在研究領域的RNA定序的利用擴大
        • 癌症研究
        • 農業研究
    • 課題
      • 定序資料的保管 (儲存) 與解釋
      • 新轉印的適合檢測的RNA定序、資料分析

第6章 NGS為基礎的RNA定序市場:產品、各類服務

  • 簡介
  • RNA定序用平台/消耗品
  • 樣品調整
    • 各工作流程
      • 程式庫調整、目標濃縮
      • 品管
    • 各手法
      • 手動式樣品調整
      • 微流體式樣品調整
      • 機器人式液體處理/樣品調整
  • RNA定序服務
  • 資料分析、記憶、管理

第7章 NGS為基礎的RNA定序市場:各技術

  • 簡介
  • SBS (Sequencing by Synthesis)
  • 離子半導體定序
  • SMRS (單一分子即時定序)
  • 奈米孔洞定序

第8章 NGS為基礎的RNA定序市場:各用途

  • 簡介
  • 表現分析分析
  • Small RNA定序
  • de novo 轉錄用集合
  • 異體、個環和轉錄、表觀遺傳學

第9章 NGS為基礎的RNA定序市場:各終端用戶

  • 簡介
  • 教育、研究機關
  • 醫院、診療所
  • 製藥、生物科技企業
  • 其他

第10章 NGS為基礎的RNA定序市場:各地區

  • 簡介
  • 北美 (美國,加拿大)
  • 歐洲 (德國,英國,法國等)
  • 亞太地區 (中國,日本,印度等)
  • 南美 (巴西,墨西哥等)
  • 中東、非洲

第11章 競爭環境

  • 簡介
  • 企業策略方向性:製圖
    • 先驅企業
    • 創新企業
    • 活動企業
    • 新企業
  • 競爭方案
  • 市場排行榜:3大公司的情況

第12章 企業簡介

  • AGILENT TECHNOLOGIES
  • BGI GROUP
  • EUROFINS SCIENTIFIC
  • GENEWIZ (BROOKS AUTOMATION的部門)
  • HAMILTON COMPANY
  • ILLUMINA
  • NUGEN TECHNOLOGIES (TECAN TRADING AG的部門)
  • OXFORD NANOPORE TECHNOLOGIES
  • PERKINELMER
  • PSOMAGEN
  • QIAGEN
  • F. HOFFMANN-LA ROCHE AG
  • TaKaRa BIO
  • THERMO FISHER SCIENTIFIC
  • ZYMO RESEARCH

第13章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 5297

"The NGS-based RNA-sequencing market is projected to grow at a CAGR of 20.0%."

The NGS-based RNA-sequencing market size is projected to reach USD 4.2 billion by 2024 from USD 1.7 billion in 2019, at a CAGR of 20.0%. Advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; rapid growth in precision medicine are the key factors driving the growth of the NGS based RNA sequencing industry.

"Pharmaceutical & biotechnology companies segment to witness the highest growth in the NGS-based RNA-sequencing market during the forecast period."

Based on the end-user, the NGS-based RNA-sequencing industry is segmented into research & academia, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. The pharmaceutical & biotechnology companies segment is expected to witness highest growth rate during the forecast period mainly due to growing number of agreements and collaborations between NGS market players and pharmaceutical & biotechnology companies for the development of advanced products.

"Expression profiling analysis application to hold the largest share in the NGS-based RNA-sequencing market."

Based on application, the NGS-based market is segmented into expression profiling analysis, small RNA-sequencing, de novo transcriptome assembly, and variant calling & transcriptome epigenetics. In 2018, the expression profiling analysis segment accounted for the largest share mainly due to the increasing prevalence of metabolic disorders, multiple sclerosis, and other diseases will propel the demand for expression profiling analysis to provide specific treatment options in the market during the forecast period.

"The Asia Pacific market is expected to witness the highest CAGR during the forecast period."

The market in Asia Pacific is projected to register the highest CAGR during the forecast period. Significant focus on R&D activities as a means of broadening the scope of RNA-Seq applications and decreasing the costs of NGS products and services are some of the key factors supporting the growth of the NGS-based RNA-sequencing market in the Asia Pacific.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1: 45%, Tier 2: 34%, and Tier 3: 21%
  • By Designation: C-level: 47%, D-level: 33%, and Others: 20%
  • By Region: North America: 35%, Europe: 32%, APAC: 25%, Latin America: 6% and Middle East & Africa: 2%

The major players operating in the NGS-based RNA-sequencing market are: Illumina (US), Thermo Fischer Scientific (US) and Oxford Nanopore (UK), Agilent Technologies, Inc. (US), BGI (China), PerkinElmer Inc. (US), QIAGEN (Germany), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd (Switzerland), Takara Bio Inc. (Japan), GENEWIZ, Inc. (US), Hamilton Company (US), Macrogen (South Korea), Zymo Research (US), and Tecan Genomics, Inc. (Switzerland) among others are the major players operating in the NGS-based RNA-sequencing market

Research Coverage:

This report studies the NGS-based RNA-sequencing market based on product & service, technology, application, end user, and region. It also covers factors affecting market growth, analyzes various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micromarkets with respect to their growth trends and forecasts the size of market segments with respect to key regions-North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa (and the respective countries in these regions).

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis-market ranking analysis of the top players and their company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the NGS-based RNA-sequencing market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY USED FOR THE STUDY
  • 1.5 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Key data from primary sources
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • 2.2.1 PRODUCT-BASED MARKET ESTIMATION
    • 2.2.2 APPLICATION-BASED MARKET ESTIMATION
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 NGS-BASED RNA-SEQUENCING: MARKET OVERVIEW
  • 4.2 NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD MILLION)
  • 4.3 NGS-BASED RNA-SEQUENCING MARKET SHARE, BY TECHNOLOGY, 2019 VS. 2024
  • 4.4 NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
  • 4.5 NGS-BASED RNA-SEQUENCING MARKET SHARE, BY END USER, 2019 VS. 2024
  • 4.6 GEOGRAPHICAL SNAPSHOT OF THE NGS-BASED RNA-SEQUENCING MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Advantages of RNA-seq over conventional technologies
      • 5.2.1.2 Increasing number of RNA-seq grants
      • 5.2.1.3 Growing number of research activities involving RNA-seq
      • 5.2.1.4 Rapid growth in precision medicine
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Lack of skilled professionals
      • 5.2.2.2 Standardization concerns of RNA-seq in diagnostic testing
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing applications of RNA-seq in research
        • 5.2.3.1.1 Cancer research
        • 5.2.3.1.2 Agricultural research
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Storage & interpretation of sequencing data
      • 5.2.4.2 Analysis of RNA-seq data for the detection of novel transcripts

6 NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
  • 6.2 RNA SEQUENCING PLATFORMS & CONSUMABLES
    • 6.2.1 INCREASING AVAILABILITY OF PLATFORMS AND GROWING CONSUMABLE USAGE HAVE ENSURED THE HIGH SHARE OF THIS SEGMENT
  • 6.3 SAMPLE PREPARATION PRODUCTS
    • 6.3.1 SAMPLE PREPARATION IS THE FIRST STEP OF AN NGS WORKFLOW
    • 6.3.2 SAMPLE PREPARATION PRODUCTS, BY WORKFLOW
      • 6.3.2.1 Library preparation & target enrichment
      • 6.3.2.2 Quality control
    • 6.3.3 SAMPLE PREPARATION PRODUCTS, BY METHOD
      • 6.3.3.1 Manual sample preparation
      • 6.3.3.2 Microfluidic sample preparation
      • 6.3.3.3 Robotic liquid handling sample preparation
  • 6.4 RNA SEQUENCING SERVICES
    • 6.4.1 LACK OF INFRASTRUCTURE AND EXPERTISE AMONG END USERS HAS DRIVEN DEMAND FOR SERVICES
  • 6.5 DATA ANALYSIS, STORAGE & MANAGEMENT
    • 6.5.1 INTEGRATION OF CLOUD COMPUTING AND BIOINFORMATICS, AMONG OTHER ADVANCEMENTS, IS CONTRIBUTING TO MARKET GROWTH

7 NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
  • 7.2 SEQUENCING BY SYNTHESIS
    • 7.2.1 SBS TECHNOLOGY ENABLES THE HIGHEST PRODUCTION OF BASE PAIRS IN A SHORT PERIOD OF TIME
  • 7.3 ION SEMICONDUCTOR SEQUENCING
    • 7.3.1 ION SEMICONDUCTOR SEQUENCING PLATFORMS POSSESS HIGH-THROUGHPUT CAPABILITIES
  • 7.4 SINGLE-MOLECULE REAL-TIME SEQUENCING
    • 7.4.1 SMRT SEQUENCING PRODUCES RESULTS IN A SHORT TIME AND AT LOWER COSTS
  • 7.5 NANOPORE SEQUENCING
    • 7.5.1 NANOPORE SEQUENCING IS THE ONLY SEQUENCING TECHNOLOGY WITH DIRECT RNA-SEQUENCING CAPABILITIES

8 NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 EXPRESSION PROFILING ANALYSIS
    • 8.2.1 INCREASING NEED FOR IMPROVED PROGNOSIS OF PATIENTS TO PROPEL MARKET GROWTH
  • 8.3 SMALL RNA SEQUENCING
    • 8.3.1 RISING NEED FOR ACCURATE DIAGNOSTIC ANALYSIS TO SUPPORT MARKET GROWTH
  • 8.4 DE NOVO TRANSCRIPTOME ASSEMBLY
    • 8.4.1 INCREASING CANCER CASES IS EXPECTED TO DRIVE THIS APPLICATION SEGMENT
  • 8.5 VARIANT CALLING & TRANSCRIPTOME EPIGENETICS
    • 8.5.1 COMPLICATED RNA-SEQ DATA ANALYSIS MAY HAMPER THE GROWTH OF THIS SEGMENT

9 NGS-BASED RNA-SEQUENCING MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 RESEARCH & ACADEMIA
    • 9.2.1 INCREASING NUMBER OF COLLABORATIONS BETWEEN NGS MARKET PLAYERS AND ACADEMIC & RESEARCH INSTITUTES TO PROPEL MARKET GROWTH
  • 9.3 HOSPITALS & CLINICS
    • 9.3.1 INCREASING ADOPTION OF NGS SYSTEMS IN HOSPITALS & CLINICS TO DRIVE MARKET GROWTH
  • 9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.4.1 CONSOLIDATION BETWEEN BIOTECH & PHARMA COMPANIES AND NGS MARKET PLAYERS TO PROPEL MARKET GROWTH
  • 9.5 OTHER END USERS

10 NGS-BASED RNA-SEQUENCING MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 US
      • 10.2.1.1 Favorable funding scenario and growing R&D activity in the US are driving market growth
    • 10.2.2 CANADA
      • 10.2.2.1 Government initiatives for genome research will boost the adoption of NGS sequencing technology
  • 10.3 EUROPE
    • 10.3.1 GERMANY
      • 10.3.1.1 Germany dominates the NGS-based RNA-sequencing market in Europe
    • 10.3.2 UK
      • 10.3.2.1 Strong presence of NGS organizations and supportive initiatives will drive market growth in the UK
    • 10.3.3 FRANCE
      • 10.3.3.1 Growing awareness on applications of high-throughput sequencing in genetic characterization will support market growth
    • 10.3.4 ROE
  • 10.4 ASIA PACIFIC
    • 10.4.1 CHINA
      • 10.4.1.1 Strong base of established players and favorable government initiatives account for China's large market share
    • 10.4.2 JAPAN
      • 10.4.2.1 Growing awareness and rising incidence of genetic disorders are driving demand for NGS-based RNA-Seq in Japan
    • 10.4.3 INDIA
      • 10.4.3.1 Rising awareness and player interest in India will drive market growth
    • 10.4.4 ROAPAC
  • 10.5 LATIN AMERICA
    • 10.5.1 BRAZIL
      • 10.5.1.1 High HIV prevalence in Brazil has driven demand for NGS in research
    • 10.5.2 MEXICO
      • 10.5.2.1 Economic growth and support for infrastructural development will drive market growth in Mexico
    • 10.5.3 ROLA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 LACK OF INFRASTRUCTURE HAS STIFLED MARKET GROWTH IN THE MEA

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 COMPETITIVE LEADERSHIP MAPPING
    • 11.2.1 TERMINOLOGY/NOMENCLATURE
      • 11.2.1.1 Visionary leaders
      • 11.2.1.2 Innovators
      • 11.2.1.3 Dynamic differentiators
      • 11.2.1.4 Emerging companies
  • 11.3 COMPETITIVE SCENARIO (2015-2019)
  • 11.4 NGS-BASED RNA-SEQUENCING MARKET RANKING, BY TOP THREE MARKET PLAYERS (2018)

12 COMPANY PROFILES

(Business overview, Products offered, Recent developments, MNM view)*

  • 12.1 AGILENT TECHNOLOGIES
  • 12.2 BGI GROUP
  • 12.3 EUROFINS SCIENTIFIC
  • 12.4 GENEWIZ (PART OF BROOKS AUTOMATION)
  • 12.5 HAMILTON COMPANY
  • 12.6 ILLUMINA
  • 12.7 NUGEN TECHNOLOGIES (PART OF TECAN TRADING AG)
  • 12.8 OXFORD NANOPORE TECHNOLOGIES
  • 12.9 PERKINELMER
  • 12.10 PSOMAGEN
  • 12.11 QIAGEN
  • 12.12 F. HOFFMANN-LA ROCHE AG
  • 12.13 TAKARA BIO
  • 12.14 THERMO FISHER SCIENTIFIC
  • 12.15 ZYMO RESEARCH

Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 2: RNA SEQUENCING PLATFORMS & CONSUMABLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 3: SAMPLE PREPARATION PRODUCTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 4: RNA SEQUENCING SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 5: DATA ANALYSIS, STORAGE & MANAGEMENT MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 6: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 7: SEQUENCING BY SYNTHESIS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8: ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 9: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 10: NANOPORE SEQUENCING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 12: EXPRESSION PROFILING ANALYSIS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13: SMALL RNA SEQUENCING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14: DE NOVO TRANSCRIPTOME ASSEMBLY MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 15: VARIANT CALLING & TRANSCRIPTOME EPIGENETICS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 16: NGS-BASED RNA-SEQUENCING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 17: NGS-BASED RNA-SEQUENCING MARKET FOR RESEARCH & ACADEMIA, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 18: NGS-BASED RNA-SEQUENCING MARKET FOR HOSPITALS & CLINICS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19: NGS-BASED RNA-SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20: NGS-BASED RNA-SEQUENCING MARKET FOR OTHER END USERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 21: NGS-BASED RNA-SEQ MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 22: NORTH AMERICA: NGS-BASED RNA-SEQ MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 23: NORTH AMERICA: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 24: NORTH AMERICA: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 25: NORTH AMERICA: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 26: NORTH AMERICA: NGS-BASED RNA-SEQ MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 27: US: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 28: US: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 29: US: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 30: CANADA: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 31: CANADA: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 32: CANADA: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 33: EUROPE: NGS-BASED RNA-SEQ MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 34: EUROPE: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 35: EUROPE: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 36: EUROPE: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 37: EUROPE: NGS-BASED RNA-SEQ MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 38: GERMANY: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 39: GERMANY: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 40: GERMANY: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 41: UK: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 42: UK: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 43: UK: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 44: FRANCE: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 45: FRANCE: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 46: FRANCE: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 47: ROE: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 48: ROE: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 49: ROE: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 50: ASIA PACIFIC: NGS-BASED RNA-SEQ MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 51: ASIA PACIFIC: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 52: ASIA PACIFIC: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 53: ASIA PACIFIC: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 54: ASIA PACIFIC: NGS-BASED RNA-SEQ MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 55: CHINA: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 56: CHINA: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 57: CHINA: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 58: JAPAN: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 59: JAPAN: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 60: JAPAN: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 61: INDIA: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 62: INDIA: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 63: INDIA: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 64: ROAPAC: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 65: ROAPAC: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 66: ROAPAC: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 67: LATIN AMERICA: NGS-BASED RNA-SEQ MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 68: LATIN AMERICA: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 69: LATIN AMERICA: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 70: LATIN AMERICA: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 71: LATIN AMERICA: NGS-BASED RNA-SEQ MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 72: BRAZIL: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 73: BRAZIL: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 74: BRAZIL: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 75: MEXICO: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 76: MEXICO: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 77: MEXICO: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 78: ROLA: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 79: ROLA: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 80: ROLA: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 81: MEA: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 82: MEA: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 83: MEA: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 84: MEA: NGS-BASED RNA-SEQ MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 85: NEW PRODUCT LAUNCHES
  • TABLE 86: ACQUISITIONS
  • TABLE 87: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARIES
  • FIGURE 3: RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 4: PRODUCT-BASED MARKET ESTIMATION: NGS-BASED RNA-SEQUENCING MARKET
  • FIGURE 5: APPLICATION-BASED MARKET ESTIMATION: NGS-BASED RNA-SEQUENCING MARKET
  • FIGURE 6: DATA TRIANGULATION
  • FIGURE 7: ASSUMPTIONS OF THE RESEARCH STUDY
  • FIGURE 8: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 9: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019 VS. 2024 (USD MILLION)
  • FIGURE 10: NGS-BASED RNA-SEQUENCING MARKET SHARE, BY APPLICATION, 2019 VS. 2024
  • FIGURE 11: NGS-BASED RNA-SEQUENCING MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
  • FIGURE 12: NGS-BASED RNA-SEQUENCING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 13: INCREASING NUMBER OF RESEARCH ACTIVITIES INVOLVING RNA-SEQ & RAPID GROWTH IN PRECISION MEDICINE TO DRIVE MARKET GROWTH
  • FIGURE 14: RNA SEQUENCING PLATFORMS & CONSUMABLES TO DOMINATE THE NGS-BASED RNA-SEQUENCING MARKET DURING THE FORECAST PERIOD
  • FIGURE 15: SEQUENCING BY SYNTHESIS SEGMENT WILL CONTINUE TO DOMINATE THE NGS-BASED RNA-SEQUENCING MARKET IN 2024
  • FIGURE 16: EXPRESSION PROFILING ANALYSIS SEGMENT DOMINATES THE NGS-BASED RNA-SEQUENCING APPLICATIONS MARKET
  • FIGURE 17: RESEARCH & ACADEMIA ARE THE LARGEST END USERS OF NGS-BASED RNA-SEQUENCING
  • FIGURE 18: CHINA IS THE FASTEST-GROWING COUNTRY IN THE NGS-BASED RNA-SEQUENCING MARKET
  • FIGURE 19: NGS-BASED RNA-SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20: GLOBAL FUNDING ACTIVITIES FOR RNA-SEQ AND MICROARRAY PROJECTS, 2009-2016
  • FIGURE 21: NUMBER OF RNA-SEQ PUBLICATIONS GLOBALLY, 2008-2016
  • FIGURE 22: NORTH AMERICA: NGS-BASED RNA-SEQ MARKET SNAPSHOT
  • FIGURE 23: EUROPE: NGS-BASED RNA-SEQ MARKET SNAPSHOT
  • FIGURE 24: ASIA PACIFIC: NGS-BASED RNA-SEQ MARKET SNAPSHOT
  • FIGURE 25: NGS-BASED RNA-SEQUENCING MARKET, COMPETITIVE LEADERSHIP MAPPING, 2018 (OVERALL MARKET)
  • FIGURE 26: NGS BASED RNA-SEQUENCING MARKET, COMPETITIVE LEADERSHIP MAPPING, 2018 (SME/START-UPS)
  • FIGURE 27: KEY DEVELOPMENTS IN THE NGS BASED RNA-SEQUENCING MARKET, 2016-2019
  • FIGURE 28: ILLUMINA HELD THE LEADING POSITION IN THE NGS BASED RNA-SEQUENCING MARKET AS OF 2018
  • FIGURE 29: AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2018)
  • FIGURE 30: EUROFINS: COMPANY SNAPSHOT (2018)
  • FIGURE 31: BROOKS AUTOMATION, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 32: ILLUMINA: COMPANY SNAPSHOT (2018)
  • FIGURE 33: TECAN: COMPANY SNAPSHOT (2018)
  • FIGURE 34: PERKIN ELMER: COMPANY SNAPSHOT (2018)
  • FIGURE 35: QIAGEN: COMPANY SNAPSHOT (2018)
  • FIGURE 36: ROCHE: COMPANY SNAPSHOT (2018)
  • FIGURE 37: TAKARA BIO: COMPANY SNAPSHOT (2017)
  • FIGURE 38: THERMO FISCHER: COMPANY SNAPSHOT (2018)